Catalent completes $5.5m expansion to help serve large-scale clinical studies

By Melissa Fassbender contact

- Last updated on GMT

(Image: Catalent Pharma Solutions)
(Image: Catalent Pharma Solutions)
The delivery technologies and development solutions provider Catalent Pharma Solutions today announced it has completed a $5.5m expansion program at its 200,000+ square foot Philadelphia, PA.

One of the largest sites in Catalent’s global clinical supply network, the expanded facility provides additional clinical packaging and storage capacity.

According to the company, the investment has resulted in a 40% increase in pallet space for both refrigerated and ambient clinical storage. It has also added extra cold chain packaging areas and a new clinical label control area. Additionally, the facility features a new environmental monitoring and building management system.

“Studies have become more global and complex, so the mix of services required to supply them has grown too,"​ said Bernie Clark, vice president of marketing and strategy for clinical supply services at Catalent.

Additionally, Clark said the company is experiencing strong growth from both long-term and new partners.

"As sponsors often don’t have all the resources themselves, they are reassessing their outsourcing strategy,"​ he told us.

Related news

Related products

show more

baxter_bloomington_facility_larger

Sterile Injectables Contract Manufacturing

Baxter BioPharma Solutions | 02-Apr-2018 | Product Brochure

Baxter BioPharma Solutions' award-winning facility in Bloomington, Indiana, USA, is a leader in sterile contract manufacturing of injectable products.

lyo_development

Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

How will Brexit affect the Pharmaceutical Industry?

How will Brexit affect the Pharmaceutical Industry?

Source BioScience Ltd | 08-Mar-2018 | Technical / White Paper

Have you prepared your strategy for the outcome of Brexit to ensure that you can continue to supply the UK market?
Source BioScience is a CRO with...

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

Related suppliers